Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Ambu A/S
  6. News
  7. Summary
    AMBU B   DK0060946788

AMBU A/S

(AMBU B)
  Report
Delayed Quote. Delayed Nasdaq Copenhagen - 10/22 10:59:54 am
186.05 DKK   -0.08%
10/15AMBU A/S : Q4 Aide-mémoire file_download
PU
10/05AMBU A/S : Preliminary results for full year 2020/21 (no. 1)
PU
10/05Ambu Announces Preliminary Revenue Results for the Year 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ambu A/S : Capital increase in connection with exercise of warrants (no. 18)

08/24/2021 | 03:44pm EDT

Aug. 2021

Capital increase in connection with exercise of warrants (no. 18)

add Details

Ambu A/S issued 770,000 warrants in 2015. Each warrant entitles the holder to subscribe for one Class B share with a nominal value of DKK 0.50. 46 individuals participate in the 2015 scheme.

For the 2015 scheme the vesting period is three years, and the scheme can therefore be exercised in the trading window that opened on 17 August 2021 in connection with Ambu's interim financial report for Q3 2020/21.

Since 17 August 2021, instructions have been received to exercise warrants as follows:

  • 2 individuals have issued instructions to exercise 10,000 warrants at the agreed exercise price of DKK 39.26 per share with a nominal value of DKK 0.50.

Today Ambu's Board of Directors decided to carry out the capital increase relating to the exercised warrants.

As a result of the capital increase, the share capital of the Company's B shares will be increased by a nominal amount of DKK 5,000 from DKK 111,686,966 to DKK 111,691,666 through the issue of 10,000 Class B shares.

Following this and in consideration of the employees having left the company, the following warrants remain under the said scheme:

  • 5,000 remaining warrants being held by 1 individual.

The new B shares are expected to be admitted to trading and official listing on NASDAQ Copenhagen A/S on 31 August 2021 under the ISIN code of Ambu A/S' existing B shares (DK0060946788).

Under section 32 of the Danish Capital Markets Act, Ambu A/S is to announce the total share capital and the total voting rights by the end of a month in which any change of the share capital was effected. The table below shows the total share capital and the total voting rights of Ambu A/S after the capital increase.

Number of shares
(nominal value DKK 0.50)
Nominal value
(DKK)
Voting rights
A shares
34,320,000
17,160,000
343,200,000
B shares
223,383,932
111,691,966
223,383,932
Total
257,703,932
128,851,966
566,583,932

Download
You can download this announcement:
Company announcement no. 18 2020/21(pdf)

Attachments

Disclaimer

Ambu A/S published this content on 24 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 August 2021 19:43:04 UTC.


© Publicnow 2021
All news about AMBU A/S
10/15AMBU A/S : Q4 Aide-mémoire file_download
PU
10/05AMBU A/S : Preliminary results for full year 2020/21 (no. 1)
PU
10/05Ambu Announces Preliminary Revenue Results for the Year 2021
CI
10/05PRESS RELEASE : iOmx Therapeutics raises EUR 65 million in Series B round
DJ
09/30AMBU A/S : Financial calendar for 2021/22 (no.19)
PU
09/22AMBU A/S : European clearance of Ambu's combined single-use bronchoscope and sampling syst..
PU
08/30AMBU A/S : commits to Science Based Targets initiative
PU
08/24AMBU A/S : Capital increase in connection with exercise of warrants (no. 18)
PU
08/18AMBU A/S : single-use duodenoscope obtains CE mark
PU
08/18AMBU A/S : European market clearance for new generation of single-use endoscopic device fr..
PU
More news
Analyst Recommendations on AMBU A/S
More recommendations
Financials
Sales 2021 4 020 M 630 M 630 M
Net income 2021 258 M 40,4 M 40,4 M
Net Debt 2021 586 M 91,8 M 91,8 M
P/E ratio 2021 180x
Yield 2021 0,18%
Capitalization 47 204 M 7 382 M 7 392 M
EV / Sales 2021 11,9x
EV / Sales 2022 10,2x
Nbr of Employees 4 500
Free-Float 65,8%
Chart AMBU A/S
Duration : Period :
Ambu A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMBU A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 186,05 DKK
Average target price 188,50 DKK
Spread / Average Target 1,32%
EPS Revisions
Managers and Directors
Juan-José Gonzalez Chief Executive Officer
Michael Højgaard CFO, EVP-Global Finance, IT & Investor Relations
Jørgen Jensen Chairman
Måns Eskil Barsne Executive VP-Global Research & Development
Henrik Ankjær Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
AMBU A/S-29.31%7 382
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815